The value of dual energy CT in Rhesus monkeys nonalcoholic fatty liver disease
SUN Feng-jiao1, LIANG Zhi-gang1, YANG Zun-yuan1, TANG Chun-gui2, CHEN Zheng-li1,
SHEN Yu-bo1, YAO Zun-wei1, WU Ming-ling1, CHEN Yuan-hai1, ZENG Wen1, GAO Fa-bao3
1. Sichuan Primed Bio-tech Group Co., Ltd, Chengdu 610000, China;
2. Department of Radiology, Ya’an People’s Hospital, Ya’an Sichuan 625000, China;
3. Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China
Abstract：Objective: To evaluate dual energy CT(DECT) diagnostic ability on nonalcoholic fatty liver disease/steatohepatitis(NAFLD/NASH), by comparing the DECT results with histopathology. Materials and Methods: Seventy Rhesus monkeys(Age >7 years, BW >7 kg, HBV and HCV negative) underwent ultrasound examination, among them 19 monkeys with moderate steatosis and 12 with mild steatosis and 6 normal monkeys took DECT examination, and within two weeks after DECT, ultrasound guided biopsy was done on 10 moderate and 8 mild steatosis and 6 normal monkeys. Results: HU100 kVp/Sn140 kVp, ΔHUSn140-100 kVp and ΔHULv-Sp（50 keV） were 0.95±0.04, (2.8±2.1) HU, (-16.4±6.3) HU; 1.02±0.03, (-0.7±1.3) HU, (-6.8±5.0) HU and 1.11±0.01, (-6.2±0.4) HU, (7.5±1.8) HU respectively. These results showed strong correlation with histopathology(R=-0.57, P<0.01; R=0.54, P<0.01; R=-0.71, P<0.001). Conclusion: The diagnostic results of DECT and the pathological results have a good consistency. As a noninvasive method, DECT showed great capacity on NAFLD diagnosis.
孙凤娇1，梁志刚1，杨遵远1，汤春贵2，陈正礼1，申渝波1，姚尊伟1，吴明玲1，陈元海1，曾 文1，郜发宝3. 双能CT技术在恒河猴非酒精性脂肪性肝病中的应用价值[J]. 中国临床医学影像杂志, 2018, 29(11): 771-774.
SUN Feng-jiao1, LIANG Zhi-gang1, YANG Zun-yuan1, TANG Chun-gui2, CHEN Zheng-li1, SHEN Yu-bo1, YAO Zun-wei1, WU Ming-ling1, CHEN Yuan-hai1, ZENG Wen1, GAO Fa-bao3. The value of dual energy CT in Rhesus monkeys nonalcoholic fatty liver disease. JOURNAL OF CHINA MEDICAL IMAGING, 2018, 29(11): 771-774.
[1]LaBrecque DR, Abbas Z, Anania F, et al. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Clin Gastroenterol, 2014, 48(9): 467-473.
[2]Bril F, Ortiz-Lopez C, Lomonaco R, et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients[J]. Liver International, 2015, 35(9): 2139-2146.
[3]Li JH, Tsai CY, Huang HM. Assessment of hepatic fatty infiltration using dual-energy computed tomography: a phantom study[J]. Physiol Measurement, 2014, 35(4): 597.
[4]Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease[J]. Gastroenterology, 2002, 123(3): 745-750.
[5]Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]. Hepatology, 2005, 41(6): 1313-1321.
[6]Zheng X, Ren Y, Phillips WT, et al. Assessment of hepatic fatty infiltration using spectral computed tomography imaging: a pilot study[J]. Comput Assist Tomogr, 2013, 37(2): 134-141.
[7]Kleiner DE, Makhlouf HR. Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children[J]. Clin Liver Dis, 2016, 20(2): 293-312.
[8]Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis[J]. Physiol Rev, 1979, 59(3): 719-809.
[9]Leclercq IA, Farrell GC, Schriemer R, et al. Leptin is essential for the hepatic fibrogenic response to chronic liver injury[J]. J Hepatol, 2002, 37(2): 206-213.
[10]Ip E, Farrell G, Hall P, et al. Administration of the potent PPARα agonist, Wy-14, 643, reverses nutritional fibrosis and steatohepatitis in mice[J]. Hepatology, 2004, 39(5): 1286-1296.
[11]Larter CZ, Yeh MM, Williams J, et al. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes[J]. J Hepatol, 2008, 49(3): 407-416.
[12]中华医学会肝脏病学会脂肪肝和酒精性肝病学组. 非酒精性脂肪肝病诊断标准[J]. 中华肝脏病杂志，2003，11（1）：71-72.
[13]Wang B, Gao Z, Zou Q, et al. Quantitative diagnosis of fatty liver with dual-energy CT[J]. Acta Radiologica, 2003, 44(1): 92-97.
[14]Hyodo T, Yada N, Hori M, et al. Multimaterial decomposition algorithm for the quantification of liver fat content by using fast-kilovolt-peak switching dual-energy CT: clinical evaluation[J]. Radiology, 2017, 283(1): 108-118.
